Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
Demonstrate the impact of the Molecular Microscope Diagnostic System as the standard of care for heart transplant patients.
| Condition(s) | Cardiac Transplant Disorder |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Demonstrate the impact of the Molecular Microscope Diagnostic System as the standard of care for heart transplant patients. |
| Who can participate | Inclusion Criteria: * biopsy for clinical indications Exclusion Criteria: * no consent * pregnant women |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | University of Alberta |
| Locations | Los Angeles, California, United States; Los Angeles, California, United States; Dallas, Texas, United States; Salt Lake City, Utah, United States; Richmond, Virginia, United States; Darlinghurst, Australia (+7 more sites) |
| Start date | 2016-01 |
| NCT ID | NCT02670408 |
| Official listing | https://clinicaltrials.gov/study/NCT02670408 |